References
  1. Gandaglia G, Briganti A, Jackson G, Kloner RA, Montorsi F, Montorsi P, Vlachopoulos C. A systematic review of the association between erectile dysfunction and cardiovascular disease. Eur Urol. 2014 May;65(5):968-78. doi: 10.1016/j.eururo.2013.08.023. Epub 2013 Aug 23. PMID: 24011423.
  2. Hatzimouratidis K, Giuliano F, Moncada I, et al. European Association of Urology (EAU). Guideline on male sexual dysfunction. 2017 Edition.
  3. Mulhall J, Teloken P, Brock G, Kim E. Obesity, dyslipidemias and erectile dysfunction: a report of a subcommittee of the sexual medicine society of North America. J Sex Med. 2006 Sep;3(5):778-786. doi: 10.1111/j.1743-6109.2006.00286.x. PMID: 16942522.
  4. Johnson EP, Dunn M, Cooper M, Bhakta N. Diabetes Prevention Program Sites Compared With Diabetes Prevalence and Ratio of Primary Care Physicians in Texas. Prev Chronic Dis. 2019 Dec 26;16:E165. doi: 10.5888/pcd16.190175. PMID: 31878987; PMCID: PMC6936669.
  5. Watanabe K, Cho YD. Periodontal disease and metabolic syndrome: a qualitative critical review of their association. Arch Oral Biol. 2014 Aug;59(8):855-70. doi: 10.1016/j.archoralbio.2014.05.003. Epub 2014 May 14. PMID: 24880501; PMCID: PMC4399819.
  6. Goh VH, Hart WG. Association of general and abdominal obesity with age, endocrine and metabolic factors in Asian men. Aging Male. 2016;19(1):27-33. doi: 10.3109/13685538.2015.1088825. Epub 2015 Oct 7. PMID: 26444311.
  7. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61. doi: 10.1016/s0022-5347(17)34871-1. PMID: 8254833.
  8. Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006 Aug 19;368(9536):666-78. doi: 10.1016/S0140-6736(06)69251-9. PMID: 16920472.
  9. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, Galluzzo A; AlkaMeSy Study Group. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010 Apr;33(4):920-2. doi: 10.2337/dc09-1825. Epub 2010 Jan 12. PMID: 20067971; PMCID: PMC2845052.
  10. Bolat MS, Kocamanoglu F, Ozbek ML, Buyukalpelli R, Asci R. Can High Visceral Adiposity Index Be a Risk Factor for Sexual Dysfunction in Sexually Active Men? J Sex Med. 2020 Oct;17(10):1926-1933. doi: 10.1016/j.jsxm.2020.06.014. Epub 2020 Jul 23. PMID: 32712095.
  11. Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol. 2002 Feb;167(2 Pt 1):624-9. doi: 10.1097/00005392-200202000-00038. PMID: 11792932.
  12. Hermans MP, Ahn SA, Rousseau MF. Erectile dysfunction, microangiopathy and UKPDS risk in type 2 diabetes. Diabetes Metab. 2009 Dec;35(6):484-9. doi: 10.1016/j.diabet.2009.06.003. PMID: 19897395.
  13. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640-5. doi: 10.1161/CIRCULATIONAHA.109.192644. Epub 2009 Oct 5. PMID: 19805654.
  14. Liu LH, Zhang T, Zhang YR, Liu TS, Zhang HB, Chen FZ, He SH, Wei AY. Metabolic syndrome and risk for ED: a meta-analysis. Int J Impot Res. 2014 Sep-Oct;26(5):196-200. doi: 10.1038/ijir.2014.3. Epub 2014 Mar 6. PMID: 24599048.
  15. Austoni E, Mirone V, Parazzini F, Fasolo CB, Turchi P, Pescatori ES, Ricci E, Gentile V; Andrology Prevention Week centres; Italian Society of Andrology. Smoking as a risk factor for erectile dysfunction: data from the Andrology Prevention Weeks 2001-2002 a study of the Italian Society of Andrology (s.I.a.). Eur Urol. 2005 Nov;48(5):810-7; discussion 817-8. doi: 10.1016/j.eururo.2005.03.005. Epub 2005 Mar 16. PMID: 16202509.
  16. Kupelian V, Link CL, McKinlay JB. Association between smoking, passive smoking, and erectile dysfunction: results from the Boston Area Community Health (BACH) Survey. Eur Urol 2007;52:416-422.
  17. Creamer MR, Wang TW, Babb S, Cullen KA, Day H, Willis G, Jamal A, Neff L. Tobacco Product Use and Cessation Indicators Among Adults - United States, 2018. MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019. doi: 10.15585/mmwr.mm6845a2. PMID: 31725711; PMCID: PMC6855510.
  18. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003 Dec;149(6):601-8. doi: 10.1530/eje.0.1490601. PMID: 14641004.
  19. Li M, Ma Z, Zhang XL, Guo LQ, Yuan MZ. Significance of blood lipid parameters as effective markers for arteriogenic erectile dysfunction. Andrology. 2020 Sep;8(5):1086-1094. doi: 10.1111/andr.12776. Epub 2020 Mar 9. PMID: 32087037.
  20. García-Cruz E, Leibar-Tamayo A, Romero J, Piqueras M, Luque P, Cardeñosa O, Alcaraz A. Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction. J Sex Med. 2013 Oct;10(10):2529-38. doi: 10.1111/jsm.12265. Epub 2013 Jul 30. PMID: 23898860.
  21. Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974 Mar;38(3):476-9. doi: 10.1210/jcem-38-3-476. PMID: 4815174.
  22. Dursun M, Besiroglu H, Cakir SS, Otunctemur A, Ozbek E. Increased visceral adiposity index associated with sexual dysfunction in men. Aging Male. 2018 Sep;21(3):187-192. doi: 10.1080/13685538.2017.1406468. Epub 2017 Nov 22. PMID: 29166824.
  23. Akdemir AO, Karabakan M, Aktas BK, Bozkurt A, Ozgur EG, Akdogan N, Yarıs M. Visceral adiposity index is useful for evaluating obesity effect on erectile dysfunction. Andrologia. 2019 Jul;51(6):e13282. doi: 10.1111/and.13282. Epub 2019 Apr 2. PMID: 30938454.
  24. Anık İlhan G, Yıldızhan B. Visceral adiposity indicators as predictors of metabolic syndrome in postmenopausal women. Turk J Obstet Gynecol. 2019 Sep;16(3):164-168.
  25. Kuneinen S, Kaaja RJ, Vahlberg TJ, Korhonen PE. Metabolic syndrome is not associated with erectile dysfunction in apparently healthy men. Prim Care Diabetes. 2020 Oct;14(5):460-463.
  26. Plata M, Caicedo JI, Trujillo CG, Mariño-Alvarez ÁM, Fernandez N, Gutierrez A, Godoy F, Cabrera M, Cataño-Cataño JG, Robledo D. Prevalence of metabolic syndrome and its association with lower urinary tract symptoms and sexual function. Actas Urol Esp. 2017 Oct;41(8):522-528.